Introduction
Human tuberculosis is a recognised complication of infection with HIV-I.' 2 In the United States a relative increase in the incidence of tuberculosis has been found in areas with high rates of AIDS, affecting certain population groups with the highest incidences of AIDS most severely.3 Many seroepidemiological studies have shown high rates of HIV-I infection in patients with tuberculosis, and cohort studies in the United States4 and Zaire' have shown that patients infected with HIV-I are at increased risk of developing active tuberculosis.
Whether or not tuberculosis is an opportunistic disease complicating infection with HIV-II is uncertain. 6 Although HIV-II infection is clearly associated with AIDS,78 it has been suggested that the natural course of this infection differs considerably from that of infection with HIV-I (P Kanki et al, fifth international conference on AIDS, Montreal, 1989 HIV-II), and synthetic peptide based tests (Peptilav 1-2, Diagnostics Pasteur, Paris).8 Specimens were characterised as reactive to either HIV-I or HIV-II, or both ("dually reactive") or non-reactive. 8 We analysed the results using computer software packages for statistical analyses (Epiinfo, version The proportions of tuberculosis cases attributable to HIV-I and HIV-II infections in patients positive for HIV (the aetiological fraction among the exposed population) and in the population as a whole (the population aetiological fraction) were calculated using standard equations'2; we assumed that the prevalence of HIV-I and HIV-II infections in volunteer blood donors was representative of that in the general population.
Results
We studied a total of 2043 consecutive patients with tuberculosis and 2127 consecutive blood donors. Of the patients with tuberculosis 1610 had confirmed pulmonary tuberculosis, 120 presumed pulmonary tuberculosis, and 313 extrapulmonary tuberculosis. Culture of a limited number of sputum smears that gave positive results yielded organisms of the Mycobacterium tuberculosis complex with no evidence of atypical mycobacteria. (R W Smithwick, personal communication). Table I shows the demographic features of patients and blood donors. Blood donors were younger than patients with tuberculosis, more of them were men, and they were more often born in the Ivory Coast. Table II shows the relative numbers of patients positive for HIV-I and HIV-II in patients with tuberculosis stratified by type of disease and in blood donors. Overall, 821 (40 2%) patients with tuberculosis were positive for HIV-I or HIV-II, or both, compared with 221 (10-4%) blood donors (odds ratio 5 8, 95% confidence interval 4 9 to 6 9). Each type of serological profile was significantly more common in patients with tuberculosis than in blood donors (table II) in each of the three categories of tuberculosis. The higher overall prevalence of HIV infection in patients with extrapulmonary tuberculosis (50 8%) or presumed pulmonary tuberculosis (44-2%) than in patients with confirmed pulmonary tuberculosis (37 8%) was due to higher levels of HIV-I infection.
Blood donors and patients with tuberculosis with HIV-Il infection were slightly older than patients with other serological profiles. The median ages of the male and female patients who were HIV-II positive were 37 years and 32 years respectively. For HIV-I infection the respective median ages in male and female patients with tuberculosis were 31 years and 25 years and for dually reactive patients 34 years and 25 years. Among blood donors a similar age distribution was seen for the different serological profiles, with HIV-II positive donors being older than those who were HIV-I positive or dually reactive. Overall, patients with tuberculosis were older than blood donors with a difference in mean or median ages between the two groups that was similar for the various serological profiles.
BMJ VOLUME 302 No cases of HIV-II infection were found in patients with confirmed pulmonary tuberculosis and blood donors aged less than 20 years, and dual reactivity in this age group was also extremely uncommon. For people aged 20-59 reactivity to HIV-I, HIV-II, and both viruses was significantly more common in patients with confirmed pulmonary tuberculosis than in blood donors (table III) .
The distribution of tuberculin skin reactivity according to serological profile is shown in the figure. 
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